- Open Access
CD4+ CD25+ FoxP3+ regulatory T cells suppress cytotoxicity of CD8+ effector T cells: implications for their capacity to limit inflammatory central nervous system damage at the parenchymal level
© BioMed Central Ltd 2012
- Received: 29 October 2011
- Accepted: 28 February 2012
- Published: 28 February 2012
CD4+ CD25+ forkhead box P3 (FoxP3)+ regulatory T cells (T reg cells) are known to suppress adaptive immune responses, key control tolerance and autoimmunity.
We challenged the role of CD4+ T reg cells in suppressing established CD8+ T effector cell responses by using the OT-I/II system in vitro and an OT-I-mediated, oligodendrocyte directed ex vivo model (ODC-OVA model).
CD4+ T reg cells dampened cytotoxicity of an ongoing CD8+ T effector cell attack in vitro and within intact central nervous system tissue ex vivo. However, their suppressive effect was limited by the strength of the antigen signal delivered to the CD8+ T effector cells and the ratio of regulatory to effector T cells. CD8+ T effector cell suppression required T cell receptor-mediated activation together with costimulation of CD4+ T reg cells, but following activation, suppression did not require restimulation and was antigen non-specific.
Our results suggest that CD4+ T reg cells are capable of suppressing CD8+ T effector cell responses at the parenchymal site, that is, limiting parenchymal damage in autoimmune central nervous system inflammation.
- CD4+ T regulatory cells
- CD8 T effector cells
- CNS parenchyma
Naturally occurring CD4+ CD25+ regulatory T cells (T reg cells) expressing the transcription factor forkhead box P3 (FoxP3) are continuously produced in the thymus and are essential for the maintenance of peripheral immunological self-tolerance and the control of a variety of physiological and pathological immune responses [1, 2].
Depletion of T reg cells or mutations in the FoxP3 gene lead to spontaneous autoimmune disease in vivo [3, 4]. In vitro coculture experiments demonstrate that naturally occurring T reg cells potently suppress proliferation and cytokine secretion of naïve CD4+ and CD8+ T cells upon stimulation with a specific antigen or with a polyclonal T cell receptor (TCR) stimulator in the presence of antigen-presenting cells (APCs) for costimulation in a cell-cell contact-dependent manner [5, 6]. Moreover, induction of the FoxP3 gene, which is considered to control the expression of key molecules mediating suppression, is capable of converting naïve CD4+ CD25- T cells into (inducible) CD4+ CD25+ T reg cells with suppressive function in vivo and in vitro [7, 8].
T reg cells can operate at different levels during the initiation and execution of an immune response. The suppressive effects of T reg cells on the initiation of an adaptive (auto)immune response in the peripheral lymphoid compartment are well known. However, their possible impact on an ongoing T cell response at the effector site is much less clear . Considering modulation of T reg cells as a potential strategy for therapeutic intervention in established autoimmune central nervous system (CNS) disorders, knowledge on the potential of T reg cells in suppressing T effector cell responses would be mandatory .
In the present work we challenge the role of T reg cells in suppressing established CD8+ T effector cell responses, by using the OT-I/II system of ovalbumin peptide (OVA) reactive CD8+ and CD4+ T cells [9, 10] in coculture experiments in vitro and in brain slice cultures from transgenic mice selectively expressing ovalbumin as a cytosolic neo-self antigen in oligodendrocytes under the control of a truncated myelin basic protein (MBP) promoter (ODC-OVA mice, [11–14]) ex vivo. Our results suggest that CD4+ T reg cells can modulate antigen-specific CD8+ T effector cell functions at the parenchymal level within intact CNS tissue in an antigen non-specific fashion.
Wild-type C57BL/6, ODC-OVA , OT-I , as well as OT-II  mice were kept under pathogen-free conditions and had access to food and water ad libitum. All experiments were conducted according to the German law of animal protection and were approved by local authorities.
T cell isolation, culture and stimulation
Isolation and stimulation of OT-I, wild-type and OT-II T reg cells was performed as previously described. Briefly, spleens were removed and single cell suspensions were generated by mashing spleens through a 40 μm strainer followed by lysis of red blood cells with ACK buffer. Splenocytes were cultured in Dulbecco's modified Eagle medium (DMEM; BioWhittaker, Verviers, Belgium) supplemented with 5% fetal calf serum (FCS; PAA Laboratories, Pasching, Germany), 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES; Gibco, Invitrogen, Darmstadt, Germany), 2 mM L-glutamine (PAA Laboratories), 50 μM 2-mercaptoethanol (Gibco, Invitrogen), 1% non-essential amino acids (BioWhittaker) and 25 μg/ml gentamicin (Gibco, Invitrogen).
OT-I splenocytes were plated at a density of 1 × 107 cells/well on a 12-well plate and primed by incubation for 5 days with OVA257-264 (SIINFEKL; Genescript, Hamburg, Germany; 1 nM) and interleukin (IL)-2 (200 IU/ml, Pepro Tech, Hamburg, Germany). After 4 days, IL-2 at a concentration of 200 IU/ml was added again to the medium. Subsequent to stimulation, H-2 Kb-restricted OT-I T cells were purified from the splenocyte suspension using the mouse CD8+ T cell isolation kit (Miltenyi, Bergisch Gladbach, Germany) following the manufacturer's instructions and yielding a purity of > 95%.
H-2 IAb-restricted CD4+ CD25+ T cells were purified from the OT-II and wild-type splenocyte suspensions using the mouse CD4 CD25 T cell isolation kit (Miltenyi) following the manufacturer's instructions. Overnight stimulation of OT-II and wild-type T reg cells was performed with 1 μg/ml anti-CD3 (immobilized) and 1 μg/ml anti-CD28 (soluble).
T cell activation status was regularly assessed by flow cytometry using the following antibodies (all by BD Bioscience, Heidelberg, Germany): rat anti-mouse CD4-PerCP (no. 553052), rat anti-mouse CD8a-PE (no. 553033), rat anti-mouse CD25-FITC (no. 554071), rat anti-mouse Alexa Fluor 647-FoxP3 (no. 560401). Flow cytometry was performed using a FACS-Calibur system (BD Bioscience) and CellQuest Pro Software (BD Bioscience).
In one set of experiments, OT-I splenocytes were stimulated with OVA257-264 for 5 days as described above with or without wild-type or OT-II T reg cells at different concentrations. Proliferating OT-I T cells were identified by prelabeling with Cell Proliferation Dye eFluor 670 (eBioscience, Frankfurt, Germany). OT-I T cell maturation markers were assessed by flow cytometry using rat anti-mouse CD8a-PerCP (no. 553036), rat anti-mouse CD44-FITC (no. 553133), rat anti-mouse CD62L-APC (no. 553152) and rat anti-mouse CD11a-PE (no. 553121) and appropriate isotype controls (all by BD Bioscience). The relation of OT-I T cells to wild-type or OT-II T reg cells was assessed by flow cytometry after cocultivation using rat anti-mouse CD4-PerCP (no. 553052) and rat anti-mouse CD8a-PE (no. 553033).
PKH26 (Sigma-Aldrich, Seelze, Germany) labeled EG.7  and EL-4 cells  were used as target cells for stimulated OT-I T cells. Cleaved caspase-3+ cells were identified after an incubation period of 6 h as early apoptotic cells measured by flow cytometry using Alexa Fluor 488-labeled rabbit anti-mouse cleaved caspase-3 (Cell Signaling, Danvers, MA, USA). OT-II T reg cells or wild-type T reg cells and OVA257-264 (SIINFEKL) were added at different concentrations as indicated.
Alternatively, 50 000 EL-4 cells/well were grown on white 96-well microassay plates (Greiner Bio-One, Frickenhausen, Germany) and incubated with different concentrations of OVA257-264 for 24 h. Afterwards, EL-4 cells were cocultured with 50.000 activated OT-I T cells (1:1) or 25.000 OT-II T reg cells (2:1) per well either alone or in combination for additional 6 h. The amount of ATP in the supernatant following cell lysis was assessed as a parameter of cell viability using the ATPLite™ Luminescence Assay System (PerkinElmer, Rodgau-Jügesheim, Germany) according to the manufacturer's instructions. Luminescence was measured on a Topcount NXT (PerkinElmer). Experiments were performed in triplicate.
Preparation of acute brain slices and coculture experiments with CD8+ T cells
Preparation of acute brain slices was performed following established procedures as described before  using naïve 6 to 10-week-old transgenic ODC-OVA mice . Brain slices were incubated alone, with 5 × 105 activated OT-I T cells per slice alone or in combination with 2.5 × 105 wild-type T reg cells or 2.5 × 105 OT-II T reg cells per slice, respectively. For upregulation of major histocompatibility complex (MHC)-I expression levels within the slices, ODC-OVA mice were treated with lipopolysaccharide (LPS; 0.2 mg/kg intraperitoneally) 24 h before slice preparation in a subset of experiments. After 6 h, slices were harvested and embedded in Tissue-Tek OCT compound.
Immunohistochemical staining was performed as previously described . Primary antibodies against neuronal nuclear antigen (NeuN; 1:1,000, Millipore, Schwalbach, Germany), NogoA (1:750; Millipore) and cleaved caspase-3 (1:200, Cell Signaling, Invitrogen) were used. Secondary antibodies were Alexa Fluor 488-coupled goat anti-mouse (1:100, BD Bioscience) and Cy3-coupled goat anti-rabbit (1:300, Dianova, Hamburg, Germany). Negative controls were obtained by either omitting the primary or secondary antibody and revealed no detectable signal (data not shown). For quantification of cell densities, sections were examined using an Axiophot2 microscope (Zeiss, Oberkochen, Germany) equipped with a CCD camera (Visitron Systems, Tuchheim, Germany). Cell density was determined within preselected fields within the cortex.
For flow cytometry analysis of intracellular effector molecule content and activation status of OT-I T cells following incubation in the slice, T cells were retrieved from slices at the end of the incubation period and pooled for each experimental condition. Cells were isolated from the interface of 30% to 50% Percoll (Amersham, Freiburg, Germany) centrifuged for 30 minutes at 2.500 rpm. Mononuclear cells were washed and stained immediately using rat anti-mouse CD8a-PE (BD Bioscience; no. 553033) and rat anti-mouse CD25-FITC (BD Bioscience; no. 554071), rat anti-mouse FoxP3 (ebioscience; 17-5773-80). For intracellular granzyme B staining, cells were pretreated with brefeldin A (BD Bioscience) for 6 h and stained with CD8a-PE followed by an intracellular staining using rabbit anti-mouse granzyme B (ab4059; Abcam, Cambridge, UK) and the secondary antibody goat anti-rabbit Cy2 (Dianova).
All results are presented as mean ± SEM. Statistical analysis was performed using one-way ANOVA with Bonferroni post hoc tests and Student's t test modified for small samples , as applicable. P values < 0.05 were considered significant (indicated as ** in figures).
FoxP3+ T reg cells suppress antigen-dependent expansion of naïve CD8+ T cells in a cell-to-cell ratio-dependent manner
Hence, following polyclonal TCR stimulation together with costimulation, both wild-type and OT-II T reg cells exert suppressive effects on the antigen-dependent expansion but not maturation of naïve OT-I T cells. This suppression is independent from their own antigen (re)stimulation as neither wild-type nor OT-II T reg cells received additional MHC class II-dependent antigen stimulation during these experiments.
The strength of the antigen stimulation of CD8+ T effector cells limits the suppressive effect of FoxP3+ T reg cells on cytotoxicity
To assess a possible suppressive effect of wild-type and OT-II T reg cells on the cytotoxic activity of activated OT-I T cells, EG.7 cells were cocultured for 6 h at a ratio of 1:1 with activated OT-I T cells alone or together with wild-type or OT-II T reg cells at a ratio of 2:1. Under these conditions wild-type (data not shown) and OT-II T reg cells (Figure 2B) did not significantly alter the number of apoptotic EG.7 cells. Constitutive expression and H-2 Kb-bound presentation of OVA257-264 by EG.7 cells (approximately 90 Kb:OVA257-264 complexes per cell [18, 19]) leads to a strong antigen-dependent perforin-granzyme-mediated killing by activated OT-I T cells, which might be hardly overcome by T reg cells under these conditions.
Therefore, we assessed a possible suppressive effect of OT-II T reg cells as well as wild-type T reg cells on OT-I T cell cytotoxicity on EL-4 cells at different OVA257-264 concentrations but otherwise unchanged conditions (Figure 2C, D). At low OVA257-264 concentrations (0.001 to 1 nM), which lead to no more than 110 Kb:OVA257-264 complexes per cell , activated OT-I T cells caused significantly lower numbers of cleaved caspase-3 positive EL-4 cells (ratio 1:1) in the presence of wild-type or OT-II T reg cells (ratio 2:1) as compared to their absence. In contrast, at high OVA257-264 concentrations (10 to 1,000 nM), which lead to up to 1,120 Kb:OVA257-264 complexes per EL-4 cell , wild-type and OT-II T reg cells (Figure 2C) did not exert any suppressive effect. This was also true when the amount of ATP released upon cell lysis was assessed as a measure of EL-4 cell viability at the end of the incubation period (Figure 2D). Importantly, non-activated OT II T reg cells and non-activated wild-type T reg cells did not exert any suppressive effect (data not shown). This excludes any unspecific effect resulting from increased total cell numbers after adding T reg cells in these experiments. Moreover, in the total absence of OVA257-264, there was a significantly higher EL-4 cell viability at the end of the incubation period, that is, no killing and therefore no suppressive effect of T reg cells (Figure 2D).
These results are consistent with the known high antigen affinity of OT-I T cells, where as few as 1 to 3 Kb:OVA257-264 complexes per target cell are sufficient to induce cytotoxicity [14, 21, 22]. This illustrates the fact that the suppressive effect of natural CD4+ T reg cells depends on the strength of this antigen stimulus delivered to the CD8+ T effector cell population. Moreover, T reg cells exert their suppressive effect independent from their own antigen (re)stimulation as neither wild-type nor OT-II T reg cells received additional MHC class II-dependent antigen stimulation during these experiments.
FoxP3+ T reg cells reduce CD8+ T cell-induced antigen-specific neural damage in acute brain slices
To assess whether T reg cells exert their suppressive effect on OT-I T cell-mediated cytotoxicity also in a more physiological environment, we incubated activated OT-I T cells in the absence and presence of OT-II T reg cells or wild-type T reg cells at a ratio of 2:1 for 6 h in acute brain slices from ODC-OVA mice. These mice selectively express ovalbumin under the control of a truncated MBP promoter as a neo-self antigen in ODCs . Incubation of activated OT-I T cells results in an ODC-directed CD8+ T cell attack in ODC-OVA slices, which leads to perforin-granzyme-dependent death of ODCs and collateral death of neurons . As these ODCs exhibit approximately 20 Kb: OVA257-264 complexes per cell , a suppressive effect of T reg cells on OT-I T cell cytotoxicity seems conceivable according to our cell culture experiments (given comparable ratios of OT-I T cells, T reg cells and ODC target cells within the slice).
During the ODC-directed OT-I T cell attack, neurons in the gray matter of ODC-OVA slices undergo collateral apoptosis . In the presence of OT-II T reg cells or wild-type T reg cells, OT-I T cell-mediated collateral neuronal damage as revealed by the density of cleaved caspase-3+ NeuN+ neurons was also significantly reduced (Figure 3A-C, right panels). Notably, background levels of cleaved caspase-3+ neurons and ODC are significantly lower than those evoked by OT-I T cell incubation (Figure 3B) and background levels are known to be higher in neurons than in ODCs  (Figure 3C).
Intraperitoneal treatment of mice with LPS is known to augment MHC I expression levels and thus antigen-peptide presentation on neural cell within 24 h . Hence, to assess how T reg cell-mediated suppression of OT-I T cell cytotoxicity in ODC-OVA slices relates to MHC I expression, ODC-OVA mice were intraperitonally treated with LPS (0.2 mg/kg) 24 h before brain slice preparation. Consistent with a LPS-enhanced MHC I expression, densities of cleaved caspase-3+ ODCs and neurons were significantly enhanced upon exposure to activated OT-I T cells (with similar background levels) in ODC-OVA slices from LPS-treated as compared to untreated mice (Figure 3D, left and right panels). Consistent with previous data on the dependence of T reg cell-mediated suppression on the antigen stimulus delivered to the CD8+ T effector cell, we observed no significant reduction of cell death of ODCs and collateral death of neurons by T reg cells under these conditions (Figure 3D, left and right panels).
To what extent T reg cells traffic to and exert their suppressive effects in parenchymal organs under autoimmune conditions is currently under debate . It was recently reported that, following their expansion in the peripheral lymphoid compartment , T reg cells accumulate and further expand in the inflamed CNS of mice undergoing experimental autoimmune encephalomyelitis (EAE). However, T reg cells isolated from the CNS of EAE mice dampened expansion of naïve but not activated encephalitogenic CD4+ T cells . Other studies found accumulation, activation and proliferation of T reg cells within the CNS during murine EAE, which was required for the resolution of inflammation and amelioration of the clinical disease [26, 27]. Moreover, application of myelin-reactive T reg cells could suppress the initiation and reverse established myelin antigen-induced EAE in mice . In these studies, up to 50% of CNS invasive CD4+ T cells could be T reg cells . However, in all these experimental systems pathology is mainly driven by CD4+ T cells.
Recently, CD8+ T cells have emerged as key players in autoimmune neuroinflammation, considered to have specific relevance for exertion of parenchymal damage . Hence, we directly tested the capability of CD4+ T reg cells to suppress terminal effector function of activated CD8+ T cells both in cell culture as well as within intact CNS tissue . Given a homogenous CD8+ T cell receptor repertoire and a fixed ratio of effector-to-regulatory T cells, CD4+ T reg cells are capable of limiting cytotoxicity of CD8+ T cells. The suppressive effect of CD4+ T reg cells at the effector site depends on the strength of the antigen signal of the target cells delivered to the CD8+ T effector cells as determined mainly by the number of antigen peptide-loaded MHC I molecules exposed on the target cell surface . The higher the OVA257-264 antigen load of EL-4 cell (which express MHC I molecules in excess; [16, 20]) or the higher the expression of (OVA257-264 antigen loaded) MHC I molecules by ODCs  in ODC-OVA slices, the weaker the relative suppressive effect of OT-II or wild-type T reg cells on the action of OT-I T effector cells. Notably, to acquire their suppressive capacity CD4+ T reg cells required activation via their T cell receptor together with a costimulatory signal, but following activation, suppression did not require restimulation and was antigen non-specific in good agreement with earlier results [29, 30].
In line with previous data obtained from lymph nodes, CD4+ T reg cells did not alter activation status but functionally impaired the release of cytotoxic granules resulting in higher intracellular levels of effector molecules in CD8+ T cells at the effector site . As a note of caution one should consider that our experimental systems do not allow an exact estimation to what extent parenchymal T reg cell-mediated T effector cell suppression influences the course and severity of systemic experimental CNS inflammation. When considering the therapeutic potential in CNS inflammation, this component would certainly be of high relevance (see for example, ).
Taken together our report demonstrates that CD4+ T reg cells are able to limit cytotoxicity of an ongoing CD8+ T effector cell attack within the intact CNS parenchyma. This effect depends on the strength of the antigen signal delivered to the CD8+ T effector cells and (presumably) the ratio of regulatory to effector T cells.
We thank Professor Dr Thomas Hünig, Institute for Virology and Immunobiology, University of Würzburg, Germany, for providing OVA-transgenic mice (ODC-OVA model) and fruitful discussions. We thank Barbara Reuter and Andrea Sauer for excellent technical assistance.
This work was supported by intramural grants of the University of Würzburg, Germany (IZKF Z-3/4) to NM and HW, and (IZKF A54-1) to SGM and HW as well as the Competence network of MS (KKNMS, Consortium UNDERSTANDMS, Alliance 'Immune regulatory networks in MS') and the DFG (B774/Wi 7-1) to HW.
- Zozulya AL, Wiendl H: The role of regulatory T cells in multiple sclerosis. Nat Clin Pract Neurol 2008, 4:384–398.View ArticlePubMedGoogle Scholar
- Shevach EM: Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 2009, 30:636–645.View ArticlePubMedGoogle Scholar
- Fontenot JD, Rudensky AY: A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005, 6:331–337.View ArticlePubMedGoogle Scholar
- Sakaguchi S: Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004, 22:531–562.View ArticlePubMedGoogle Scholar
- Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, Shimizu J, Sakaguchi S: Immunologic self-tolerance maintained by CD25 + CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998, 10:1969–1980.View ArticlePubMedGoogle Scholar
- Thornton AM, Shevach EM: CD4 + CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitr by inhibiting interleukin 2 production. J Exp Med 1998, 188:287–296.View ArticlePubMedPubMed CentralGoogle Scholar
- Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057–1061.View ArticlePubMedGoogle Scholar
- Khattri R, Cox T, Yasayko SA, Ramsdell F: An essential role for Scurfin in CD4 + CD25+ T regulatory cells. Nat Immunol 2003, 4:337–342.View ArticlePubMedGoogle Scholar
- Barnden MJ, Allison J, Heath WR, Carbone FR: Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 1998, 76:34–40.View ArticlePubMedGoogle Scholar
- Kurts C, Heath WR, Carbone FR, Allison J, Miller JF, Kosaka H: Constitutive class I-restricted exogenous presentation of self antigens in vivo . J Exp Med 1996, 184:923–930.View ArticlePubMedGoogle Scholar
- Cao Y, Toben C, Na SY, Stark K, Nitschke L, Peterson A, Gold R, Schimpl A, Hunig T: Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes. Eur J Immunol 2006, 36:207–215.View ArticlePubMedGoogle Scholar
- Melzer N, Meuth SG, Wiendl H: CD8+ T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability. FASEB J 2009, 23:3659–3673.View ArticlePubMedGoogle Scholar
- Gobel K, Melzer N, Herrmann AM, Schuhmann MK, Bittner S, Ip CW, Hunig T, Meuth SG, Wiendl H: Collateral neuronal apoptosis in CNS gray matter during an oligodendrocyte-directed CD8(+) T cell attack. Glia 2010, 58:469–480.PubMedGoogle Scholar
- Meuth SG, Herrmann AM, Simon OJ, Siffrin V, Melzer N, Bittner S, Meuth P, Langer HF, Hallermann S, Boldakowa N, Herz J, Munsch T, Landgraf P, Aktas O, Heckmann M, Lessmann V, Budde T, Kieseier BC, Zipp F, Wiendl H: Cytotoxic CD8+ T cell-neuron interactions: perforin-dependent electrical silencing precedes but is not causally linked to neuronal cell death. J Neurosci 2009, 29:15397–15409.View ArticlePubMedGoogle Scholar
- Moore MW, Carbone FR, Bevan MJ: Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988, 54:777–785.View ArticlePubMedGoogle Scholar
- Bevan MJ, Cohn M: Cytotoxic effects of antigen- and mitogen-induced T cells on various targets. J Immunol 1975, 114:559–565.PubMedGoogle Scholar
- Dixon W, Massey FJ: Introduction to Statistical Analysis. New York, USA: McGraw-Hill Companies; 1969.Google Scholar
- Malarkannan S, Afkarian M, Shastri N: A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells. J Exp Med 1995, 182:1739–1750.View ArticlePubMedGoogle Scholar
- Rotzschke O, Falk K, Stevanovic S, Jung G, Walden P, Rammensee HG: Exact prediction of a natural T cell epitope. Eur J Immunol 1991, 21:2891–2894.View ArticlePubMedGoogle Scholar
- Na SY, Eujen H, Gobel K, Meuth SG, Martens K, Wiendl H, Hunig T: Antigen-specific blockade of lethal CD8 T-cell mediated autoimmunity in a mouse model of multiple sclerosis. J Immunol 2009, 182:6569–6575.View ArticlePubMedGoogle Scholar
- Purbhoo MA, Irvine DJ, Huppa JB, Davis MM: T cell killing does not require the formation of a stable mature immunological synapse. Nat Immunol 2004, 5:524–530.View ArticlePubMedGoogle Scholar
- Sykulev Y, Joo M, Vturina I, Tsomides TJ, Eisen HN: Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 1996, 4:565–571.View ArticlePubMedGoogle Scholar
- Terao A, Apte-Deshpande A, Dousman L, Morairty S, Eynon BP, Kilduff TS, Freund YR: Immune response gene expression increases in the aging murine hippocampus. J Neuroimmunol 2002, 132:99–112.View ArticlePubMedGoogle Scholar
- Walker LS, Chodos A, Eggena M, Dooms H, Abbas AK: Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo . J Exp Med 2003, 198:249–258.View ArticlePubMedPubMed CentralGoogle Scholar
- Korn T, Reddy J, Gao W, Bettelli E, Awasthi A, Petersen TR, Bäckström BT, Sobel RA, Wucherpfennig KW, Strom TB, Oukka M, Kuchroo VK: Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 2007, 13:423–431.View ArticlePubMedPubMed CentralGoogle Scholar
- McGeachy MJ, Stephens LA, Anderton SM: Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4 + CD25+ regulatory cells within the central nervous system. J Immunol 2005, 175:3025–3032.View ArticlePubMedGoogle Scholar
- O'Connor RA, Malpass KH, Anderton SM: The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells. J Immunol 2007, 179:958–966.View ArticlePubMedGoogle Scholar
- Stephens LA, Malpass KH, Anderton SM: Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg. Eur J Immunol 2009, 39:1108–1117.View ArticlePubMedGoogle Scholar
- Piccirillo CA, Shevach EM: Cutting edge: control of CD8+ T cell activation by CD4 + CD25+ immunoregulatory cells. J Immunol 2001, 167:1137–1140.View ArticlePubMedGoogle Scholar
- Thornton AM, Shevach EM: Suppressor effector function of CD4 + CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 2000, 164:183–190.View ArticlePubMedGoogle Scholar
- Mempel TR, Pittet MJ, Khazaie K, Weninger W, Weissleder R, von Boehmer H, von Andrian UH: Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 2006, 25:129–141.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.